Shoulder Innovations, INC

Shoulder Innovations, Inc. announced the closing of up to $50 million in new credit facilities with Stifel Bank, including a $15 million term loan to refinance existing debt and a $30 million revolving line of credit for working capital.

Shoulder Innovations, Inc. successfully concluded its 2026 Annual Meeting of Stockholders, confirming the election of two directors and the ratification of its independent auditor.

Shoulder Innovations reported a 65% year-over-year increase in first-quarter net revenue to $16.7 million and raised its full-year 2026 revenue guidance.

Shoulder Innovations announces the full commercial launch of its InSet I-135RFX Humeral Stem, expanding its product line for all primary, revision, and fracture total shoulder arthroplasty procedures.

Shoulder Innovations, Inc. has entered into a 10-year lease agreement for a new 15,200 sq ft corporate headquarters expected to be completed in Q4 2027.

Shoulder Innovations, Inc. announced the appointment of medical technology veteran Drew Hykes to its Board of Directors, replacing Geoff Pardo.

Shoulder Innovations, Inc. announced its first quarter 2026 financial results, showcasing a significant 64.9% increase in net revenue to $16.7 million, driven by higher implant system sales and an expanded customer base.

Shoulder Innovations, Inc. reported a significant increase in net revenue for Q3 2025, driven by higher implant system sales, following its successful Initial Public Offering in August 2025.

Shoulder Innovations, Inc. reported a 33.3% increase in net revenue for the second quarter of 2025, reaching $11.013 million, but also saw its net loss widen significantly to $19.196 million, influenced by fair value adjustments and public company transition costs, following its recent IPO.

Healthcare Holding B.V. Gilde, a 10% owner of Shoulder Innovations, Inc., sold 48,279 shares of common stock on July 30, 2026.

Casey M. Tansey, a Director and 10% owner of Shoulder Innovations, Inc. (SI), reported the acquisition of 5,046 shares of common stock on June 26, 2026.

Kevin K. Sidow, a Director at Shoulder Innovations, Inc., acquired 5,046 restricted stock units on June 26, 2026, as part of a compensation award.

Andrew Hykes, a Director at Shoulder Innovations, Inc., acquired 5,046 shares of common stock through an award of restricted stock units.

Paul Buckman, a Director at Shoulder Innovations, Inc., acquired 5,046 restricted stock units (RSUs) on June 26, 2026, as part of an award.

Richard Buchholz, a Director at Shoulder Innovations, Inc., acquired 5,046 restricted stock units.

Shoulder Innovations, Inc. invites stockholders to its 2026 Annual Meeting on June 26, 2026, to elect directors and ratify auditor appointment.

Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, is pursuing an initial public offering of 5 million shares to fund its rapid growth, despite reporting increasing net losses and significant operating expenses.

Shoulder Innovations, a medical technology company focused on shoulder surgical care, filed an S-1/A for its initial public offering, showcasing significant revenue growth but also increasing net losses and detailing a recent $40 million convertible note financing.

Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, filed an S-1/A amendment for its initial public offering, revealing significant revenue growth, continued net losses, and plans to list on the NYSE under the symbol 'SI'.

Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, has filed an S-1 registration statement for an initial public offering, showcasing significant revenue growth and strategic plans for market expansion and product innovation.

Gilde Healthcare has increased its beneficial ownership in Shoulder Innovations, Inc. to 11.8% following the company's initial public offering and conversion of preferred stock.

Several key individuals and an LLC have filed an amendment to Schedule 13G, reporting their beneficial ownership of Shoulder Innovations, Inc. common stock.

Lightstone Ventures II and its affiliates, including managing directors, have reported beneficial ownership of 9.3% of Shoulder Innovations, Inc.'s common stock.

U.S. Venture Partners and affiliates disclose significant passive beneficial ownership in Shoulder Innovations, Inc., with Casey M. Tansey holding a 13.3% stake.

A group led by cultivate(MD) Holdings, LLC has reported a 6.7% beneficial ownership stake in Shoulder Innovations, Inc., totaling 1,363,394 shares.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 19.0% of Shoulder Innovations Inc.'s common stock as of August 29, 2025.

Arboretum Ventures VI, L.P. and its affiliates have disclosed a 5.8% beneficial ownership stake in Shoulder Innovations, Inc., totaling 1,163,891 shares.